Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP - 1 Aug 2011

Pahore Zaen-Al-Abideen, Shamsi Tahir S, Taj Mehwesh, Farzana Tasneem, Ansari Saqib H, Nadeem Muhammad, Ahmad Masood, Naz Arshi

Abstract excerpt

OBJECTIVE: To determine the association of JAK2V617F mutation along with BCR-ABL translocation or Philadelphia chromosome in chronic myeloid leukemia with early disease progression to advanced stages (accelerated phase or blast crisis) and poor outcome. STUDY DESIGN: Case series. PLACE AND DURATION OF STUDY: National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, from February 2008 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blast Crisis
Share to Confidence Intervals

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemoglobins

Share to Janus Kinase 2

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Philadelphia Chromosome

Share to Risk Assessment

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 21798133
DOI: 08.2011/JCPSP.472475

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.PMID 21798133Read ↗

Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?Semantic proximity Read ↗

Rare Case of Accelerated-Phase Chronic Myeloid Leukemia Diagnosed During Treatment for JAK2 V617F-Positive Primary Myelofibrosis.Semantic proximity Read ↗

Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemiaSemantic proximity Read ↗

Blast phase of chronic myeloid leukemia presenting lymphoid phenotype with a chronic phase of extremely short duration.Semantic proximity Read ↗

BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation.Semantic proximity Read ↗

Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy.Semantic proximity Read ↗

Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?Semantic proximity Read ↗

Chronic myeloid leukemia blast crisis arises from progenitors.Semantic proximity Read ↗

Molecular events in chronic myeloid leukemia progression.Semantic proximity Read ↗

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.Semantic proximity Read ↗

The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.Semantic proximity Read ↗

Presentation of chronic myeloid leukemia as promyelositic blastic transformation: A case report and literature reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.